Joanna Ożga

Dr. Joanna Ożga

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Joanna OżgaJoanna Ożga
Joanna Ożga
MWMichał Wyka
Michał Wyka
ARAgata Raczko
Agata Raczko
ZTZbisław Tabor
Zbisław Tabor
ZOZuzanna Oleniacz
Zuzanna Oleniacz
WWWadim Wojciechowski
Wadim Wojciechowski
This study evaluates the performance of a fully automated algorithm to detect active inflammation in the form of bone marrow edema (BME) in iliac and sacral bones, depending on the quality of the coronal oblique plane in patients with axial spondyloarthritis (axSpA). The results were assessed based on the technical correctness of MRI examination of the sacroiliac joints (SIJs). A total of 173 patients with suspected axSpA were included in the study. In order to verify the correctness of the MRI, a deviation angle was measured on the slice acquired in the sagittal plane in the T2-weighted sequence. This angle was located between the line drawn between the posterior edges of S1 and S2 vertebrae and the line that marks the actual plane in which the slices were acquired in T1 and STIR sequences. All examinations were divided into quartiles according to the deviation angle measured in degrees as follows: 1st group [0; 2.2], 2nd group (2.2; 5.7], 3rd group (5.7; 10] and 4th group (10; 29.2]. Segmentations of the sacral and iliac bones were acquired manually and automatically using the fully automated algorithm on the T1 sequence. The Dice coefficient for automated bone segmentations with respect to reference manual segmentations was 0.9820 (95% CI [0.9804, 0.9835]). Examinations of BME lesions were assessed using the SPARCC scale (in 68 cases SPARCC > 0). Manual and automatic segmentations of the lesions were performed on STIR sequences and compared. The sensitivity of detection of BME ranged from 0.58 (group 1) to 0.83 (group 2) versus 0.76 (total), while the specificity was equal to 0.97 in each group. The study indicates that the performance of the algorithm is satisfactory regardless of the deviation angle.

1 June 2023 in Molecular Imaging and Radionuclide Therapy
Verified
Journal Article
Open access
Jan RoczniakJan Roczniak
Jan Roczniak
JBJustyna Bączalska
Justyna Bączalska
GKGabriela Kanclerz
Gabriela Kanclerz
WZWeronika Zielińska
Weronika Zielińska
Joanna OżgaJoanna Ożga
Joanna Ożga
KHKatarzyna Holcman
Katarzyna Holcman
The pharmacological stress test with vasodilator agents is an alternative cardiological diagnostic tool for patients with contraindications to the classical stress test provided by physical activity during single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI). The study compared the frequency of the side effects of regadenoson and dipyridamole during a SPECT MPI. This retrospective study included data of 283 consecutive patients who underwent pharmacological stress tests in years 2015-2020. The study group consisted of 240 patients who had received dipyridamole and 43 patients who had received regadenoson. The collected data included the patients' characteristics, the occurrence of side effects (divided into mild: headache, vertigo, nausea, vomiting, dyspnea, chest discomfort, hot flushes, general weakness and severe: bradycardia, hypotension, loss of consciousness), and blood pressure values/measurements. Overall, complications occurred relatively often (regadenoson: 23.2%, dipirydamol: 26.7%, p=0.639). Procedure discontinuation was necessary in 0.7% of examinations, whereas pharmacological support was necessary in 4.7%. There was no difference in the prevalence of mild (regadenoson: 16.2%, dipirydamol: 18.3%, p=0.747) and severe complications (regadenoson: 11.6%, dipyridamole: 15.0%, p=0.563). However, regadenoson has been found to cause a significantly smaller mean decrease of systolic blood pressure (SBP) (regadenoson: -2.6±10.0 mmHg, dipyridamole: -8.7±9.6 mmHg, p=0.002), diastolic blood pressure (DBP) (regadenoson: -0.9±5.4 mmHg, dipyridamole: -3.6±6.2 mmHg, p=0.032), as well as mean arterial pressure (MAP) (regadenoson: -1.5±5.6 mmHg, dipyridamole: -5.4±6.5 mmHg, p=0.001). Regadenoson and dipyridamole presented a similar safety profile during SPECT MPI. However, regadenoson has been found to cause significantly smaller decreases in SBP, DBP, and MAP.

12 July 2024 in Rheumatology
Verified
Journal Article
Open access
Joanna OżgaJoanna Ożga
Joanna Ożga
EMElżbieta Mężyk
Elżbieta Mężyk
WKWojciech Kmiecik
Wojciech Kmiecik
WWWadim Wojciechowski
Wadim Wojciechowski
ZZZbigniew Zuber
Zbigniew Zuber
Magnetic resonance imaging (MRI) of the musculoskeletal system is an examination increasingly performed for suspected juvenile idiopathic arthritis, chronic nonbacterial osteomyelitis and juvenile idiopathic inflammatory myopathies, as well as other rheumatic diseases of developmental age. T1-, T2- and PD-weighted with or without fat suppression or short tau inversion recovery/turbo inversion recovery magnitude (STIR/TIRM) sequences and post-contrast sequences are evaluated to diagnose pathological changes in the synovial membrane, subchondral bone marrow and surrounding soft tissues. Magnetic resonance imaging allows detection of synovitis, tenosynovitis, bursitis, and enthesitis as well as bone marrow edema and soft tissue edema. Several pediatric-specific MRI scoring systems have been developed and validated to standardize and facilitate the assessment of the extent of the inflammatory process and disease activity in MRI. Early detection of inflammatory changes allows the inclusion of comprehensive pharmacotherapy giving the possibility of permanent remission and objective measurement of the effectiveness of treatment.

26 November 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Joanna OżgaJoanna Ożga
Joanna Ożga
Monika OstrogórskaMonika Ostrogórska
Monika Ostrogórska
WWWadim Wojciechowski
Wadim Wojciechowski
ZZZbigniew Zuber
Zbigniew Zuber
Background: Sacroiliitis in children is usually connected with one of the subtypes of juvenile idiopathic arthritis (JIA), such as enthesitis-related arthritis, psoriatic arthritis, or undifferentiated arthritis. The main diagnostic method is magnetic resonance imaging (MRI) of the sacroiliac joints, which can reveal bone marrow edema (BME) as a sign of an active inflammation process. This research aimed to retrospectively investigate the associations between the clinical presentation, laboratory test results, and MRI results of the sacroiliac joints of children. Methods: A total of 152 paediatric patients who underwent MRI of the sacroiliac joints were included in this single-centre study. The mean age of patients was 13.91 ± 2.97, while the female-to-male ratio was 1.36:1. JIA diagnosis was confirmed in 91 (59.87%) patients. Results: The main symptom reported by 128 (83.21%) patients was chronic pain, while in another 40 (31.25%) patients, it was chronic back pain. Patients with arthritis and BME in the sacroiliac joints were more likely to report chronic back pain, while patients with JIA but without BME in the sacroiliac joints were often positive for anti-nuclear antibodies (ANA). The widening of any joint contour was observed in 43 (28.29%) patients, and reduced joint mobility was observed in 61 (40.13%). Elevation of inflammatory blood parameters occurred in 31 (20.39%) patients, but this was not statistically related to BME presence in the sacroiliac joints. Radiological findings included BME (n = 36; 23.68% of examinations), joint space narrowing (n = 10; 27.78% of examinations), erosions (n = 7; 19.44% of examinations), and joint fluid (n = 7; 19.44% of examinations). There was a statistically significant relationship between the presence of BME in the sacroiliac joints and all of the above radiological findings. Conclusions: The radiological findings of MRI of the sacroiliac joints are significantly statistically related to chronic back pain in patients, while there is no relationship between any inflammatory blood parameter and the presence of BME.

30 September 2024 in Rheumatology Forum
Verified
Journal Article
Open access
PDF file
Joanna OżgaJoanna Ożga
Joanna Ożga
ARAgata Raczko
Agata Raczko
ZOZuzanna Oleniacz
Zuzanna Oleniacz
WWWadim Wojciechowski
Wadim Wojciechowski
ZŻZbigniew Żuber
Zbigniew Żuber
Background: Juvenile idiopathic arthritis (JIA) is a chronic inflammatory joint disease with a complex etiology. It is characterised by symptoms such as swelling, exudates, soreness, and reduced mobility. Early diagnosis and treatment are crucial to improving long-term prognosis and preventing complications. Case presentation: A 5-year-old girl with polyarticular seronegative, human leukocyte antigen B27 (HLA-B27)-positive JIA previously under the care of another medical centre was admitted for evaluation of disease activity and possible reintroduction of treatment. The patient's history began at the age of 14 months when symptoms of inflammation of the small joints of the hands appeared. On physical examination pain and swelling of the proximal interphalangeal joints of the hands were detected. Laboratory tests revealed low inflammatory indices. Rheumatoid factor, anti-citrullinated protein antibodies, and a genetic test for HLA-Cw6 were negative. An ultrasound of the hands confirmed the presence of arthritis. Furthermore, a magnetic resonance imaging (MRI) scan and a computed tomography (CT) scan were performed, revealing sacroiliitis. The treatment initially included two disease-modifying drugs — methotrexate and sulphasalazine with folic acid shielding. Subsequently, due to the poor response to treatment, the child was qualified for biological treatment with adalimumab, achieving a significant improvement in clinical condition and imaging findings. Follow-up hospital admissions confirmed the stabilisation of the patient's condition and the absence of disease progression. Conclusion: This case emphasises the importance of early diagnosis and an individualised therapeutic approach in the treatment of JIA. Biological therapy with adalimumab, combined with conventional drugs, proved effective in controlling the disease's symptoms and improving the patient's quality of life. Keywords: juvenile idiopathic arthritis MRI adalimumab musculoskeletal system

28 August 2024 in Medicina
Verified
Journal Article
Open access
PDF file
Joanna OżgaJoanna Ożga
Joanna Ożga
Monika OstrogórskaMonika Ostrogórska
Monika Ostrogórska
WWWadim Wojciechowski
Wadim Wojciechowski
ZZZbigniew Zuber
Zbigniew Zuber
Background and Objectives: The diagnosis of rheumatic diseases in children is challenging and requires the use of advanced imaging examinations such as whole-body magnetic resonance imaging (MRI). Whole-body MRI allows visualization of bone marrow edema (BME), muscle edema, joint effusion and changes in the soft tissues surrounding the joints. The aim of this study was to collect and compare whole-body MRI findings, laboratory results and clinical manifestations of pediatric patients with suspected rheumatic disease. Materials and methods: In this retrospective single-center study, 33 patients who underwent whole-body MRI were included. Their age ranged from 9 to 17 years, and 24 (72.73%) of the patients were female. Patients were diagnosed as follows: juvenile idiopathic arthritis (27.27%), juvenile idiopathic inflammatory myopathies (21.21%), chronic nonbacterial osteomyelitis (21.21%) and other medical conditions (30.30%), such as arthritis associated with infection, scleroderma, Takayasu arteritis, polyarteritis nodosa and joint damage. Results: The most common symptom reported by 26 (79.79%) patients was pain. On physical examination, the limitation of joint mobility was examined in 17 (51.51%), swelling of the joints was observed in 12 (36.36%) patients and decreased muscle strength was noticed in 11 (33.33%) patients. An increase in the C-reactive protein (12%), erythrocyte sedimentation rate (9%), leukocyte count (9%) and creatine kinase (CK) (18%) was observed. Whole-body MRI revealed myositis (30%), joint effusion (27%) and BME (24%). The statistical analysis showed a significant relationship between myositis and the elevated CK level (p < 0.05). Conclusions: The most common symptom in the studied population was pain, while the limitation of joint mobility was found in more than half of patients. Myositis was the most commonly imaged lesion on the whole-body MRI and it was related to an increase in the CK level.